Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE;ORAL - EQ 10MG BASE
USFDA APPLICATION NUMBER - 205353
DOSAGE - CAPSULE;ORAL - EQ 15MG BASE
USFDA APPLICATION NUMBER - 205353
DOSAGE - CAPSULE;ORAL - EQ 20MG BASE
USFDA APPLICATION NUMBER - 205353
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Co-Processed Excipients
Chewable & Orodispersible Aids
Taste Masking
Thickeners and Stabilizers
Lubricants & Glidants
Disintegrants & Superdisintegrants
Granulation
Controlled & Modified Release
Parenteral
Coating Systems & Additives
Film Formers & Plasticizers
API Stability Enhancers
Rheology Modifiers
Emulsifying Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Panobinostat lactate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Panobinostat lactate, including repackagers and relabelers. The FDA regulates Panobinostat lactate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Panobinostat lactate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Panobinostat lactate supplier is an individual or a company that provides Panobinostat lactate active pharmaceutical ingredient (API) or Panobinostat lactate finished formulations upon request. The Panobinostat lactate suppliers may include Panobinostat lactate API manufacturers, exporters, distributors and traders.
click here to find a list of Panobinostat lactate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Panobinostat lactate DMF (Drug Master File) is a document detailing the whole manufacturing process of Panobinostat lactate active pharmaceutical ingredient (API) in detail. Different forms of Panobinostat lactate DMFs exist exist since differing nations have different regulations, such as Panobinostat lactate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Panobinostat lactate DMF submitted to regulatory agencies in the US is known as a USDMF. Panobinostat lactate USDMF includes data on Panobinostat lactate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Panobinostat lactate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Panobinostat lactate suppliers with USDMF on PharmaCompass.
A Panobinostat lactate written confirmation (Panobinostat lactate WC) is an official document issued by a regulatory agency to a Panobinostat lactate manufacturer, verifying that the manufacturing facility of a Panobinostat lactate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Panobinostat lactate APIs or Panobinostat lactate finished pharmaceutical products to another nation, regulatory agencies frequently require a Panobinostat lactate WC (written confirmation) as part of the regulatory process.
click here to find a list of Panobinostat lactate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Panobinostat lactate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Panobinostat lactate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Panobinostat lactate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Panobinostat lactate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Panobinostat lactate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Panobinostat lactate suppliers with NDC on PharmaCompass.
Panobinostat lactate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Panobinostat lactate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Panobinostat lactate GMP manufacturer or Panobinostat lactate GMP API supplier for your needs.
A Panobinostat lactate CoA (Certificate of Analysis) is a formal document that attests to Panobinostat lactate's compliance with Panobinostat lactate specifications and serves as a tool for batch-level quality control.
Panobinostat lactate CoA mostly includes findings from lab analyses of a specific batch. For each Panobinostat lactate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Panobinostat lactate may be tested according to a variety of international standards, such as European Pharmacopoeia (Panobinostat lactate EP), Panobinostat lactate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Panobinostat lactate USP).
LOOKING FOR A SUPPLIER?
